BMRN vs RDVT · P/E 40, rev $1.76B vs P/E 78, rev $52.5M
Biomarin Pharmaceutical Inc (BMRN) versus Red Violet Inc (RDVT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Red Violet Inc (RDVT) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported RDVT revenue for 2026-06-30 was $52.5M. Net income was $9.3M. RDVT currently screens at market cap $663.2M and trailing P/E 77.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. RDVT currently screens at market cap $663.2M and trailing P/E 77.9.
Not investment advice. Open the BMRN and RDVT stock pages for the full models.
Not investment advice.